Baupost Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Baupost Group's ELV Position: Q2 2026 in Review
Baupost Group held its Elevance Health (ELV) position steady in Q2 2026 at 1,275,154 shares worth $493M. The position accounts for 9.11% of the portfolio, ranked #2.
Baupost Group first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Baupost Group held 1,275,154 shares of Elevance Health worth $493M as of Q2 2026.
- Baupost Group left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 9.11% of Baupost Group's portfolio in Q2 2026, its #2 holding.
- Baupost Group first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Baupost Group's 13F filing for Q2 2026, filed 13 Aug 2026.